| 注册
首页|期刊导航|中国临床药理学杂志|磷酸西格列汀改善2型糖尿病 KKAy小鼠糖脂代谢及作用机制探讨

磷酸西格列汀改善2型糖尿病 KKAy小鼠糖脂代谢及作用机制探讨

刘率男 刘泉 侯少聪 王悦 申竹芳

中国临床药理学杂志Issue(3):206-211,6.
中国临床药理学杂志Issue(3):206-211,6.DOI:10.13699/j.cnki.1001-6821.2015.03.015

磷酸西格列汀改善2型糖尿病 KKAy小鼠糖脂代谢及作用机制探讨

Sitagliptin improves glucose and lipids metabolism by regulating hepatic transcription factor phosphorylation-forkhead box O1 in diabetic KKAy mice

刘率男 1刘泉 1侯少聪 1王悦 1申竹芳1

作者信息

  • 1. 中国医学科学院、北京协和医学院 药物研究所天然药物活性物质与功能国家重点实验室,北京 100050
  • 折叠

摘要

Abstract

Objective To evaluate the effects of the sitagliptin ( Sita) on glucose and lipids metabolism in type 2 diabetic KKAy mice.Methods Female diabetic KKAy mice selected by insulin tolerance test ( ITT) were divided into two groups.Model group ( Mod) was orally administered by gavage with water, Sita group at a dose of 15 mg· kg-1 · d -1 for about 90 days.ITT, glucose tolerance tests ( OGTT ) , intraperitoneal sodium pyruvate tolerance test were determined.Fasting plasma lipids, glucose, insulin levels and hepatic lipids contents were detected at the end of treatment.Pancreas morphology changes andβcell mass were evaluated by hematoxylin-eosin, insulin and glucagon stainning.The changes of protein expression in the liver were also analyzed by Western Bolt.Results Sita significantly improved insulin sensitivity, glucose intolerance and gluconeogenesis in diabetic KKAy mice.Fasting plasma glucose were decreased and insulin levels increased after 90 days Sita treatment (P<0.05, P <0.001).In addition, lipid profiles such as plasma triglyceride (TG, P<0.01), total cholesterol (TC, P<0.01), high density lipoprotein cholesterol ( HDC-C, P<0.01) and low densi-ty lipoprotein cholesterol ( LDL-C, P<0.01 ) levels and TC contents&nbsp;( P<0.05 ) were also significantly diminished after Sita treatment.It was shown that Sita up-regulated the hepatic protein expression of phosphorylation-forkhead box O1 (phospho-FoxO1, P<0.01).Moreover, the protein expres-sion of gluconeogenesis related glucose-6 -phosphatase ( G6 P ) and phosphoenolpyruvate carboxykinase ( PEPCK ) were decreased in Sita group ( P<0.01, P<0.001) , and fatty acid synthesis related fatty acid synthase ( FAS) were also decreased ( P<0.001).Conclusion These results indicated that chronic administration of Sita improved dyslipi-demia and glucose homeostasis in diabetic KKAy mice, which is related to up-regulation of the hepatic expression of phospho-FoxO1 , which involved in gluconeogenesis and lipid metabolism.

关键词

磷酸西格列汀/2型糖尿病KKAy小鼠/叉头蛋白1/糖异生/脂肪酸合成酶

Key words

sitagliptin/diabetic KKAy mice/forkhead box O1/gluconeogenesis/fatty acid synthetase

分类

医药卫生

引用本文复制引用

刘率男,刘泉,侯少聪,王悦,申竹芳..磷酸西格列汀改善2型糖尿病 KKAy小鼠糖脂代谢及作用机制探讨[J].中国临床药理学杂志,2015,(3):206-211,6.

基金项目

国家科技重大专项-重大新药创制基金资助项目 ()

中国临床药理学杂志

OA北大核心CSCDCSTPCD

1001-6821

访问量0
|
下载量0
段落导航相关论文